Day: July 23, 2024

NV5 Awarded $5 Million NOAA Contract for Lake Michigan Geospatial Hydrographic Survey

HOLLYWOOD, Fla., July 23, 2024 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, conformity assessment, and consulting solutions, announced today that it has been awarded a $5 million contract by the National Oceanic and Atmospheric Administration (NOAA) Office of Coast Survey to conduct a comprehensive hydrographic survey in Lake Michigan. “NV5’s geospatial marine surveying business continues its strategic expansion into new geographies to support water resource management, maritime safety, and updated navigational information,” said Dickerson Wright, PE, Executive Chairman of NV5. “NV5’s specialized expertise in hydrographic surveying and nautical charting makes us uniquely qualified to support commercial and recreational maritime safety efforts by providing essential...

Continue reading

First Watch Restaurant Group, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024

Conference call and webcast to be held the same day at 8:00 AM ET BRADENTON, Fla., July 23, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced that it plans to release its second quarter 2024 financial results on Tuesday, August 6, 2024, before the market opens. A conference call and webcast will follow at 8:00 AM ET, hosted by Chris Tomasso, Chief Executive Officer and President, and Mel Hope, Chief Financial Officer. Interested parties may listen to the conference call via any one of three options: Dial 201-389-0914, which will be answered by an operator Pre-register by entering your information at this Call Me™ link Join the webcast at https://investors.firstwatch.com/news-and-events/events The...

Continue reading

Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France

MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today the publication of the reimbursement of Inspire therapy in France. “We are thrilled to offer our clinically proven treatment option for moderate to severe OSA to patients and physicians in France,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire. “Inspire therapy is backed by a strong body of evidence and years of clinical experience demonstrating the safety and efficacy of our therapy.” Inspire therapy received European Conformity Marking for commercialization in Europe in 2010. Since that time, the company’s approach has been...

Continue reading

Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists

Group to Advise on the Application of Ovid’s Novel Pipeline Programs to Broader Disorders of the Brain Neurologists/epileptologists Dr. Imad Najm of the Cleveland Clinic Neurological Institute and the Cleveland Clinic Epilepsy Center, and Dr. Raman Sankar, the Emeritus Chief of Pediatric Neurology at UCLA Health, appointed to Ovid’s Scientific Advisory Board (SAB) Neuroscientists Dr. Jamie Maguire of Tufts University and Dr. Jeff Noebels of Baylor College of Medicine, appointed to the SAB to contribute expertise in neurophysiology, hyperexcitability and network effects The SAB will advise on the potential application of Ovid’s compounds to broader disorders in which they may offer therapeutic promise, including brain conditions caused by hyperexcitability, neurovascular and neuro-inflammatory dysfunction NEW YORK, July 23, 2024 (GLOBE...

Continue reading

Jayud Global Logistics Partners with Leading Southeast Asian E-commerce Provider Lazbao Group

Agreement to Expand into the Fastest Growing E-commerce Market in the World SHENZHEN, China, July 23, 2024 (GLOBE NEWSWIRE) — Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced a Strategic Cooperation Agreement (the “Agreement”) with Lazbao Group (“Lazbao”), a leading full-service e-commerce logistics service provider in Southeast Asia. The Agreement aims to establish future chartered air services from Jayud across Lazbao’s existing service areas in Southeast Asia. According to eMarketer, a market research company that provides insights and trends related to digital marketing, media, and commerce, the Southeast Asian market was the fastest-growing e-commerce...

Continue reading

Global Mofy Reports YoY $9.8 million Increase in Net Income for the Six Months Ended March 31, 2024

Company to Host Investor Call on Tuesday, July 23, 2024, at 8.30 am ET Revenue achieved a record of $19.9 million, up 55.3% from $12.8 Million. Gross Profit Increased by 135.1% to $11.8 Million from $5.0 Million. Gross Margin Expanded to 59.3% from 39.2%. EPS Surged by 1537.9% to $0.37 from $0.02. BEIJING, July 23, 2024 (GLOBE NEWSWIRE) — Global Mofy Metaverse Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today reported financial results for the six months ended March 31, 2024, with revenue, gross margin, and EPS all surging on a year-over-year basis to new company records. “The digital revolution is transforming industries worldwide,...

Continue reading

Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET

WARREN, N.J., July 23, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced that it will report results for the second quarter ended June 30, 2024 and provide an update on recent developments in its business after market close on Tuesday, August 6, 2024. Management will host a conference call for investors at 8:00 a.m. ET on Wednesday, August 7, 2024. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on Aquestive’s website at: Second Quarter 2024 Earnings Call Following the call, a replay of the...

Continue reading

Data Intelligence Firm Cyabra Plans to List on NASDAQ Through a Business Combination with Trailblazer Merger Corporation I

Cyabra’s AI Tools Empower Corporations and Governments in the Fight Against Disinformation Campaigns Elon Musk Engaged Cyabra to Analyze the Amount of Bot Activity Prior to His Acquisition of Twitter1 New York & Tel Aviv, July 23, 2024 (GLOBE NEWSWIRE) — Cyabra Strategy Ltd. (“Cyabra”), a provider of an AI-powered solution for combating worldwide disinformation, and Trailblazer Merger Corporation I (“Trailblazer”) (NASDAQ: TBMC), a special purpose acquisition company, announced today the signing of a definitive agreement for a business combination that upon closing is expected to result in Cyabra being publicly listed on the NASDAQ. The spread of disinformation is one of the most pressing challenges facing society today, undermining trust in brands, individuals, communities, and democratic institutions. At a time when students...

Continue reading

Critical Metals Corp Completes Stage 1 of the Tanbreez Acquisition, One of the World’s Largest Rare Earth Deposits

Critical Metals Corp Board of Directors Concludes Due Diligence on Tanbreez Acquisition; Critical Metals Corp Issues 8.4 Million Ordinary Shares to Acquire 36.45% of Outstanding Shares of Tanbreez Mining Greenland A/S NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) — Critical Metals Corp (Nasdaq: CRML) (“Critical Metals Corp”), a leading mining development company focused on critical metals and minerals and producing strategic products essential to electrification and next generation technologies for Europe and its Western world partners, today announced that it has completed Stage 1 of its recently announced plan to acquire a controlling interest in the Tanbreez Greenland Rare Earth Mine (the “Tanbreez Project”) from Rimbal Pty Ltd., a company controlled by geologist Gregory Barnes (“Rimbal”). In exchange for a 36.45% interest in Tanbreez...

Continue reading

Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024

BOSTON, July 23, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 6, 2024 to report its second quarter 2024 financial results and provide a corporate update. To access the live conference call, participants may register here. While not required, it is recommended that participants join the call ten minutes prior to the scheduled start. Also today, Rhythm announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in a fireside chat at the upcoming Canaccord Genuity 44th Annual Growth Conference in Boston, MA on Tuesday,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.